Achmea Investment Management B.V. boosted its stake in shares of Metlife Inc (NYSE:MET) by 13.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,107 shares of the financial services provider’s stock after buying an additional 4,974 shares during the quarter. Achmea Investment Management B.V.’s holdings in Metlife were worth $1,919,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in MET. Kaizen Advisory LLC lifted its holdings in Metlife by 148.0% during the 2nd quarter. Kaizen Advisory LLC now owns 2,515 shares of the financial services provider’s stock worth $110,000 after buying an additional 1,501 shares during the period. Flagship Harbor Advisors LLC acquired a new position in Metlife during the 2nd quarter worth about $110,000. FNY Investment Advisers LLC acquired a new position in Metlife during the 2nd quarter worth about $112,000. LFA Lugano Financial Advisors SA acquired a new position in Metlife during the 2nd quarter worth about $130,000. Finally, Tuttle Tactical Management acquired a new position in Metlife during the 2nd quarter worth about $144,000. 77.42% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Chairman Steven A. Kandarian sold 42,805 shares of the business’s stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $47.03, for a total value of $2,013,119.15. Following the transaction, the chairman now directly owns 559,097 shares of the company’s stock, valued at approximately $26,294,331.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Steven A. Kandarian sold 85,683 shares of the business’s stock in a transaction dated Tuesday, August 21st. The shares were sold at an average price of $46.93, for a total value of $4,021,103.19. Following the completion of the transaction, the chairman now directly owns 585,005 shares in the company, valued at $27,454,284.65. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Several research analysts have commented on MET shares. Zacks Investment Research raised Metlife from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a report on Friday, October 5th. Credit Suisse Group cut their target price on Metlife from $67.00 to $63.00 and set an “outperform” rating on the stock in a report on Friday, August 17th. Wells Fargo & Co set a $60.00 target price on Metlife and gave the stock a “buy” rating in a report on Friday, November 2nd. UBS Group lifted their target price on Metlife from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Monday, October 8th. Finally, Morgan Stanley lifted their target price on Metlife from $52.00 to $54.00 and gave the stock an “equal weight” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $54.00.

Shares of NYSE:MET opened at $45.46 on Wednesday. The stock has a market capitalization of $44.60 billion, a PE ratio of 10.10, a price-to-earnings-growth ratio of 0.68 and a beta of 1.30. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.14 and a current ratio of 0.14. Metlife Inc has a 1 year low of $39.31 and a 1 year high of $55.21.

Metlife (NYSE:MET) last announced its quarterly earnings data on Thursday, November 1st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. The company had revenue of $16.40 billion for the quarter, compared to the consensus estimate of $15.88 billion. Metlife had a return on equity of 9.76% and a net margin of 7.62%. The firm’s revenue was down 2.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.09 EPS. On average, equities research analysts forecast that Metlife Inc will post 5.31 EPS for the current fiscal year.

Metlife announced that its Board of Directors has approved a share repurchase plan on Thursday, November 1st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 4.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Tuesday, November 6th will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.70%. The ex-dividend date is Monday, November 5th. Metlife’s dividend payout ratio is 37.33%.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/11/14/achmea-investment-management-b-v-buys-4974-shares-of-metlife-inc-met.html.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: What is a conference call?

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.